Nevertheless, conflicting findings noted in studies of autoimmune diseases such as systemic lupus erythematosus (58–61) have implicated both excessive and attenuated TLR9 signaling levels, thus further investigations are needed to clarify its precise role in PI-IBS susceptibility. This evidence concerns the gene TLR9 and irritable bowel syndrome.